Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (US20170277845) Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues

Office : United States of America
Application Number: 15621363 Application Date: 13.06.2017
Publication Number: 20170277845 Publication Date: 28.09.2017
Grant Number: 10325071 Grant Date: 18.06.2019
Publication Kind : B2
IPC:
G01N 33/48
G06F 19/00
G16B 35/00
G16B 40/00
G16B 50/00
G16C 20/60
G16H 50/20
G06G 7/58
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
G PHYSICS
06
COMPUTING; CALCULATING; COUNTING
F
ELECTRIC DIGITAL DATA PROCESSING
19
Digital computing or data processing equipment or methods, specially adapted for specific applications
[IPC code unknown for G16B 35][IPC code unknown for G16B 40][IPC code unknown for G16B 50][IPC code unknown for G16C 20/60][IPC code unknown for G16H 50/20]
G PHYSICS
06
COMPUTING; CALCULATING; COUNTING
G
ANALOGUE COMPUTERS
7
Devices in which the computing operation is performed by varying electric or magnetic quantities
48
Analogue computers for specific processes, systems, or devices, e.g. simulators
58
for chemical processes
CPC:
G16B 35/00
G06F 19/3418
G16B 40/00
G16B 50/00
G16C 20/60
G16H 50/20
Y02A 90/26
Applicants: uBiome, Inc.
Inventors: Zachary Apte
Daniel Almonacid
Jessica Richman
Agents: Kilpatrick Townsend & Stockton LLP
Priority Data:
Title: (EN) Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
Abstract: front page image
(EN)

A method for at least one of characterizing, diagnosing and treating a neurological health issue in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the neurological health issue based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the neurological health issue; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.